Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension

NCT02279160 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: APD811
DRUG: Placebo

Sponsor

United Therapeutics